(Q31899830)

English

The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 July 2017

The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group (English)

1 reference

Europe PubMed Central

4 July 2017

1 reference

based on heuristic

inferred from title

author name string

Nowak-Göttl U

1

1 reference

Europe PubMed Central

4 July 2017

Sträter R

2

1 reference

Europe PubMed Central

4 July 2017

Kosch A

3

1 reference

Europe PubMed Central

4 July 2017

von Eckardstein A

4

1 reference

Europe PubMed Central

4 July 2017

Schobess R

5

1 reference

Europe PubMed Central

4 July 2017

Luigs P

6

1 reference

Europe PubMed Central

4 July 2017

Nabel P

7

1 reference

Europe PubMed Central

4 July 2017

Vielhaber H

8

1 reference

Europe PubMed Central

4 July 2017

Kurnik K

9

1 reference

Europe PubMed Central

4 July 2017

Junker R

10

1 reference

Europe PubMed Central

4 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2001

1 reference

Europe PubMed Central

4 July 2017

European Journal of Haematology

1 reference

Europe PubMed Central

4 July 2017

66

1 reference

Europe PubMed Central

4 July 2017

1

1 reference

Europe PubMed Central

4 July 2017

57-62

1 reference

Europe PubMed Central

4 July 2017

Lifestyle and hemostatic risk factors for ischemic heart disease : the Caerphilly Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Cerebrovascular disease in infants and children: A study of incidence, clinical features, and survival

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Stroke in children. Clinical characteristics and prognosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Stroke in childhood.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Genetic analysis of the thermolabile variant of 5, 10-methylenetetrahydrofolate reductase as a risk factor for ischemic stroke.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study on 225 patients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Prospective study of endogenous tissue plasminogen activator and risk of stroke

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Activated protein C resistance in childhood stroke

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

The 4G/4G genotype at nucleotide position -675 in the promotor region of the plasminogen activator inhibitor 1 (PAI-1) gene is less frequent in young patients with minor stroke than in controls

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

21 January 2018

Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombophilic disorders in children with cerebral infarction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated tissue plasminogen activator antigen and stroke risk: The Stroke Prevention In Young Women Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Computed tomographic patterns of proven embolic brain infarctions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasminogen Activator Inhibitor-1 (PAI-1) Antigen Plasma Levels in Subjects Attending a Metabolic Ward: Relation to Polymorphisms of PAI-1 and Angiontensin Converting Enzyme (ACE) Genes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

7 January 2021

based on heuristic

inferred from DOI database lookup

The PAI-1 Gene Locus 4G/5G Polymorphism Is Associated With a Family History of Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasminogen activator inhibitor-1 4G/5G-polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00338.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1600-0609.2001.00338.X

1 reference

Europe PubMed Central

4 July 2017

1 reference

Europe PubMed Central

4 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31899830&oldid=1964168094"